Prospective Observational Study to Evaluate the Efficacy and Safety of Treatment With "Allergovac Poliplus" in Polysensitized Patients With Allergic Rhinitis/Rhinoconjunctivitis, With or Without Associated Asthma
Latest Information Update: 24 Oct 2021
At a glance
- Drugs Allergy immunotherapy (Primary)
- Indications Allergic rhinitis; Allergic rhinoconjunctivitis
- Focus Therapeutic Use
- Acronyms ARES
- Sponsors Roxall Medizin GmbH
Most Recent Events
- 19 Oct 2021 Status changed from active, no longer recruiting to completed.
- 29 Jun 2020 Planned End Date changed from 30 May 2020 to 30 Jun 2021.
- 29 Jun 2020 Planned primary completion date changed from 30 May 2020 to 30 Jun 2021.